Medscint scintillation dosimetry experts will be traveling to Austria to connect with world-leading medical physicists and radiotherapy specialists at the ESTRO 2025 Annual Scientific Meeting, taking place at the Austria Center Vienna from May 2nd to May 6th in the stunning and historic city of Wien.
A Rich and Engaging Scientific Program
ESTRO 2025 will host Europe’s largest industry exhibition in radiation oncology, providing a chance to interact with industry leaders, discover the latest technological innovations, and explore advancements in radiotherapy techniques and products.
It features a top-tier scientific program spanning four days with up to 12 parallel tracks, covering key topics like brachytherapy, clinical radiotherapy, medical physics, radiobiology, and advancements in radiation oncology. Sessions will include symposia, debates, teaching lectures, panel discussions, scientific presentations, and much more. This edition will also emphasize the future of radiotherapy and address challenges in access to optimal treatment worldwide.
Meet Medscint Experts at ESTRO 2025
If you’re attending ESTRO 2025 in Vienna, don’t miss the opportunity to meet our Medscint scintillation dosimetry experts in person at our booth #873:
- Jonathan Turcotte, Eng., MBA (Physics Eng., CMO and Co-founder)
- Danahé LeBlanc, MSc (Medical Physicist)
Medscint Innovation: Elevating Radiotherapy
Medscint continues to set the benchmark for real-time dosimetry with its HYPERSCINT™ technology, designed for demanding applications such as small-field dosimetry, real-time adaptive QA (e.g., MR-Linac), and ultra-high dose rate irradiation protocols (UHDR or FLASH-RT).
Key features of HYPERSCINT™ include:
✅ Fast real-time dose measurements at multiple locations simultaneously.
✅ Water-equivalent detector design improving accuracy without perturbations or correction factors.
✅ Miniature sensitive volume (down to 0.1 mm³) ensuring high spatial resolution.
✅ Exclusive hyperspectral Cherenkov removal technique, providing robust angular independence over 4π.
✅ Linear response across a wide range of dose rates, from out-of-field to ultra-high dose rates.
✅ Metal-free detector design, eliminating artifacts when used in high-strength magnetic fields.
Medscint’s Collaborations Showcased at the ESTRO 2025
Medscint is already working with renowned research collaborators in 15 countries accros the globe. Look for the latest abstracts and results available this year at the ESTRO 2025 conference in Vienna:
📖 Experimental characterization of a single point plastic scintillation detector for in-vivo dosimetry in HDR Brachytherapy
👉 Abstract 4552 – Chahrazed Ghannoudi, CANADA
Physics Brachytherapy Proffered Papers – Room Strauss 3 / Sun 04 May 17:00 – 18:00
📖 Validation of a commercial scintillator detector system for IMRT treatment plan verification on an MR-linac
👉 Abstract 458 – Hans Lynggaard Riis, DENMARK / Digital Poster
📖 Time-resolved and multi-point dose measurements in a novel deformable and MRI-compatible beating heart phantom
👉 Abstract 4129 – Manon M.N Aubert, NETHERLANDS / Digital Poster
📖 Motion mitigation in 2-fraction prostate SBRT using MRI-guided MLC-tracking
👉 Abstract 4279 – Prescilla Uijtewaal, NETHERLANDS / Digital Poster